cholest-5-ene-3,4-diol has been researched along with Chronic Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahng, MY; Cho, H; Cho, JY; Jang, IJ; Kim, AH; Kim, YS; Lee, S; Oh, J; Yoon, SH; Yu, KS | 1 |
1 other study(ies) available for cholest-5-ene-3,4-diol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229).
Topics: Adult; Aged; Chromatography, Liquid; Cortisone; Cytochrome P-450 CYP3A; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Glomerular Filtration Rate; Humans; Hydrocortisone; Hydroxycholesterols; Male; Middle Aged; Piperazines; Renal Insufficiency, Chronic; Republic of Korea; Severity of Illness Index; Tandem Mass Spectrometry | 2017 |